Keurig Dr Pepper
KDP
30.54
-0.59
-1.90%
Keurig Dr Pepper
US · KDP
#540 by market cap
Listed 1970
30.54
-0.59
-1.90%
Live - 5344 symbols - heartbeat 115s ago
· 2026-10-08 03:44
After-hours
30.55
+0.03%
Overnight
30.41
-0.43%
- Market cap
- 41.56B
- P/E (TTM)i
- 30.85
- P/Bi
- 1.66
- EPSi
- 1.53
- Div yieldi
- 3.01%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on KDP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.43, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.16% YoY
Margins
- Gross margin
- 54.20%
- Operating margin
- 22.00%
- Net margin
- 12.52%
Key ratios & quality
- Enterprise valuei
- 56.67B
- PEG ratioi
- 2.35
- Altman Z-Scorei
- 1.43
PEG uses trailing P/E against the 3-year net income growth rate (13.13%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.44B | 11.12B | 11.62B | 12.68B | 14.06B | 14.81B | 15.35B | 16.60B |
| Gross profit | 3.88B | 6.34B | 6.49B | 6.98B | 7.32B | 8.08B | 8.53B | 9.00B |
| Selling & admin expenses | 2.64B | 3.96B | 3.98B | 4.15B | 4.65B | 4.91B | 5.01B | 5.35B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.24B | 2.38B | 2.55B | 2.89B | 2.78B | 3.19B | 3.31B | 3.65B |
| Pretax profit | 791.00M | 1.69B | 1.75B | 2.80B | 1.72B | 2.76B | 1.91B | 2.69B |
| Tax | 202.00M | 440.00M | 428.00M | 653.00M | 284.00M | 576.00M | 473.00M | 608.00M |
| Net profit | 589.00M | 1.25B | 1.33B | 2.15B | 1.44B | 2.18B | 1.44B | 2.08B |
| Basic EPS | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 |
| Diluted EPS | 0.53 | 0.88 | 0.93 | 1.50 | 1.01 | 1.55 | 1.05 | 1.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.64B | 4.16B | 4.31B | 4.50B | 3.98B | 7.31B |
| Gross profit | 1.99B | 2.26B | 2.34B | 2.42B | 2.10B | 3.07B |
| Selling & admin expenses | 1.19B | 1.36B | 1.34B | 1.46B | 1.34B | 2.40B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 801.00M | 898.00M | 995.00M | 959.00M | 756.00M | 628.00M |
| Pretax profit | 660.00M | 718.00M | 852.00M | 457.00M | 357.00M | 305.00M |
| Tax | 143.00M | 171.00M | 190.00M | 104.00M | 87.00M | 95.00M |
| Net profit | 517.00M | 547.00M | 662.00M | 353.00M | 270.00M | 210.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.38 | 0.40 | 0.49 | 0.26 | 0.20 | 0.04 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.16B | 2.27B | 2.39B | 3.06B | 3.80B | 3.38B | 4.00B | 5.27B |
| Cash & ST investments | 83.00M | 75.00M | 240.00M | 567.00M | 535.00M | 267.00M | 510.00M | 1.03B |
| Inventory | 626.00M | 654.00M | 762.00M | 894.00M | 1.31B | 1.14B | 1.30B | 1.73B |
| Total assets | 48.92B | 49.52B | 49.78B | 50.60B | 51.84B | 52.13B | 53.43B | 55.46B |
| Total current liabilities | 5.70B | 6.47B | 7.69B | 6.49B | 8.08B | 8.92B | 8.09B | 8.29B |
| Short-term debt | 1.48B | 1.70B | 2.46B | 459.00M | 1.09B | 3.47B | 2.64B | 3.11B |
| Long-term debt | 14.20B | 12.83B | 11.14B | 11.58B | 11.07B | 9.95B | 12.91B | 13.04B |
| Total liabilities | 26,385,000,000.00 | 26,261,000,000.00 | 25,949,000,000.00 | 25,626,000,000.00 | 26,712,000,000.00 | 26,454,000,000.00 | 29,187,000,000.00 | 29,943,000,000.00 |
| Total equity | 22.53B | 23.26B | 23.83B | 24.97B | 25.13B | 25.68B | 24.24B | 25.52B |
| Retained earnings | 1.18B | 1.58B | 2.06B | 3.20B | 3.54B | 4.56B | 4.79B | 5.62B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.35B | 4.61B | 4.70B | 5.27B | 23.13B | 9.46B |
| Cash & ST investments | 653.00M | 509.00M | 516.00M | 1.03B | 898.00M | 1.52B |
| Inventory | 1.54B | 1.74B | 1.84B | 1.73B | 1.83B | 3.86B |
| Total assets | 53.70B | 54.37B | 54.61B | 55.46B | 73.14B | 87.62B |
| Total current liabilities | 9.17B | 7.22B | 7.53B | 8.29B | 10.03B | 19.74B |
| Short-term debt | 4.27B | 2.26B | 2.57B | 3.11B | 4.82B | 8.39B |
| Long-term debt | 11.93B | 13.92B | 13.53B | 13.04B | 20.89B | 21.59B |
| Total liabilities | 29,252,000,000.00 | 29,383,000,000.00 | 29,281,000,000.00 | 29,943,000,000.00 | 43,958,000,000.00 | 58,391,000,000.00 |
| Total equity | 24.45B | 24.99B | 25.32B | 25.52B | 29.18B | 29.23B |
| Retained earnings | 5.00B | 5.23B | 5.58B | 5.62B | 5.58B | 5.33B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.61B | 2.47B | 2.46B | 2.87B | 2.84B | 1.33B | 2.22B | 1.99B |
| Depreciation & amortization | 434.00M | 658.00M | 653.00M | 708.00M | 709.00M | 720.00M | 733.00M | 753.00M |
| Free cash flow | 1.43B | 2.11B | 1.94B | 2.42B | 2.46B | 848.00M | 1.60B | 1.49B |
| Dividends paid | -232.00M | -844.00M | -846.00M | -955.00M | -1.08B | -1.14B | -1.19B | -1.25B |
| Stock buybacks / issuance | 9.00B | 0 | 29.00M | 140.00M | -379.00M | -706.00M | -1.11B | -9.00M |
| Ending cash balance | 139.00M | 111.00M | 255.00M | 568.00M | 535.00M | 267.00M | 608.00M | 1.04B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 209.00M | 431.00M | 639.00M | 712.00M | 281.00M | 895.00M |
| Depreciation & amortization | 163.00M | 200.00M | 191.00M | 199.00M | 185.00M | 694.00M |
| Free cash flow | 75.00M | 323.00M | 527.00M | 563.00M | 163.00M | 712.00M |
| Dividends paid | -312.00M | -313.00M | -312.00M | -313.00M | -312.00M | -366.00M |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 751.00M | 565.00M | 569.00M | 1.04B | 18.72B | 1.55B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.69 | 5.48 | 5.63 | 8.79 | 5.73 | 8.59 | 5.77 | 8.36 |
| ROA %i | 1.99 | 2.55 | 2.67 | 4.28 | 2.80 | 4.20 | 2.73 | 3.82 |
| ROIC %i | 4.06 | 4.51 | 4.64 | 6.61 | 5.24 | 6.50 | 4.86 | 6.40 |
| 5-year avg ROE %i | 31.15 | 26.09 | 20.39 | 14.31 | 6.06 | 6.84 | 6.90 | 7.45 |
| EBIT margin %i | 16.70 | 21.12 | 20.29 | 26.00 | 17.16 | 21.96 | 17.26 | 20.73 |
| FCF / sales %i | 19.26 | 18.97 | 16.69 | 19.07 | 17.49 | 5.72 | 10.40 | 8.96 |
| Current ratioi | 0.38 | 0.35 | 0.31 | 0.47 | 0.47 | 0.38 | 0.49 | 0.64 |
| Quick ratioi | 0.23 | 0.19 | 0.18 | 0.28 | 0.27 | 0.20 | 0.25 | 0.33 |
| Debt / assetsi | 32.69 | 30.75 | 29.09 | 26.22 | 26.20 | 28.44 | 29.11 | 29.10 |
| LT debt / equityi | 64.38 | 58.15 | 50.45 | 51.29 | 49.72 | 44.24 | 53.26 | 51.09 |
| Interest coveragei | 2.75 | 3.59 | 3.90 | 6.60 | 3.48 | 6.56 | 3.60 | 4.56 |
| Revenue CAGR (3Y) %i | 5.81 | 19.97 | 20.20 | 19.45 | 8.13 | 8.44 | 6.57 | 5.71 |
| Net income CAGR (3Y) %i | -8.46 | 13.97 | 7.19 | 54.14 | 4.62 | 18.07 | -12.43 | 13.13 |
| FCF CAGR (3Y) %i | 19.77 | 39.37 | 32.69 | 19.07 | 5.24 | -24.09 | -12.93 | -15.41 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.13 | 6.18 | 6.29 | 8.36 | 7.37 | 5.38 |
| ROA %i | 2.84 | 2.88 | 2.95 | 3.82 | 2.89 | 1.89 |
| ROIC %i | 4.90 | 4.90 | 5.13 | 6.40 | 5.40 | 4.38 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.30 | 17.18 | 17.55 | 20.73 | 19.30 | 15.00 |
| FCF / sales %i | 11.44 | 9.99 | 9.89 | 8.96 | 9.30 | 9.78 |
| Current ratioi | 0.47 | 0.64 | 0.62 | 0.64 | 2.31 | 0.48 |
| Quick ratioi | 0.24 | 0.31 | 0.30 | 0.33 | 0.24 | 0.20 |
| Debt / assetsi | 32.85 | 32.39 | 32.14 | 29.10 | 35.15 | 34.22 |
| LT debt / equityi | 54.69 | 61.45 | 59.16 | 51.09 | 82.70 | 86.23 |
| Interest coveragei | 3.81 | 3.98 | 3.72 | 4.56 | 3.69 | 2.89 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Coffee and related products is the largest reported line at 48.17% of revenue, across 4 reported segments.
- Liquid refreshment beverages (LRB) follows at 46.00%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Coffee and related products48.17%
Liquid refreshment beverages (LRB)46.00%
Other3.80%
Appliances2.02%
Quote time 2026-10-08 03:44:10 · For reference only, not investment advice and not tailored to your situation.